WhichRecall
Class IIIReported 2025-06-18

Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90

Recalled by Glenmark Pharmaceuticals Inc., USA

Reason for Recall

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.

Advertisement
Recall Number
D-0462-2025
Classification
Class III
Status
Ongoing
Category
drug
Initiated
2025-05-19
Reported
2025-06-18
Distribution
Nationwide USA and PR
Code Info
Lot #: 17240195, Exp 01/31/2026.
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement